Sign Up and Stay connected to us

Track and monitor the latest market updates, launches and upcoming market entrants, news of Indian regulatory affairs and our fresh service offerings- to revamp your business strategies, combat competition and stay differentiated in the highly evolving and dynamic Indian market. Have the power, delivered to your inbox, every month. The newsletter will keep you cognizant about our latest offers and best deals on availing specific services. Your contact details and email are strictly secured with us. Please feel free to send across your queries according to your business needs.

Market Assessment

In order to evaluate the attractiveness of your target market, you need to stay up-to-date about the disease/therapy area of interest, its treatment landscape, upcoming/emerging therapies, clinical trials, target patient pool (Epidemiology), unmet medical needs and other market dynamics.

Advantages from Admirus Market Assessment Portfolio:

Utilizing our balanced blend of scientific and market knowledge with business analytics expertise, you can get benefit from the following types of analyses:

  • Disease Overview: Know-how of disease, its classification/stages, causes, symptoms, risk factors, pathophysiology, diagnosis etc. 
  • Treatment Landscape: Treatment guidelines, treatment algorithms, current treatment options, SOC, detailed profiling of the approved products
  • Patient Segmentation and Specific Treatments: Are there currently any specific treatment for some specific patient pool
  • Pipeline Assessment: Identifying and tracking the emerging therapies/molecules in clinical development (from Phase I through Phase III) for indication of interest; Evaluating their potential; Probability of regulatory and clinical success; Clinical trial analysis, benchmarking and roadmap; Pivot trial analysis and learning from failed trials; Upcoming product launches
  • Clinical Trial Analysis: To capture and profile all the relevant trials of the pipeline products; Trial end-point analysis
  • Trial Map Designing: A pictorial presentation of the start date and expected end date for all the pipeline molecules, with information on phase, sub-indication, enrolment and recruitment status
  • MoA Analysis: Identifying emerging mechanism of action and pathways for new product development
  • Unmet Need Evaluation: Prevailing unmet needs that can be targeted
  • Commercialization / Market Attractiveness Assessment:Competitor and portfolio analysis (Marketed products and companies); Scenario planning;Message recall assessment;Conference coverage; Discussion forum analysis;Commercial opportunities evaluation
  • Epidemiology Analysis:Estimation of target market size in terms of patients;Derivation of incidence, prevalence, drug treated patient pool, survival rate, mortality, etc. for different indications by geographiesof interest
  • Patent Analysis/ Generic Competition Analysis: Tracking patent expiry timelines of the blockbuster drugs, generic entries and generic erosion in various therapeutic markets
  • Market Entry Opportunity Analysis: Identifying the potential and order of entry for your key products into various geographies/countries of interest (based on the demographics, healthcare infrastructure and regulations, healthcare expenditure, patient population, compliance rate, etc. in those countries)
  • Business Development and Licensing Opportunity Assessments: Identifying in-licensing and out-licensing opportunities and the size of those opportunities; Evaluating partners of choice for strategic business agreements/deals